vs

Side-by-side financial comparison of Dexcom (DXCM) and Lumentum Holdings Inc. (LITE). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $665.5M, roughly 1.9× Lumentum Holdings Inc.). Dexcom runs the higher net margin — 21.2% vs 11.8%, a 9.5% gap on every dollar of revenue. On growth, Lumentum Holdings Inc. posted the faster year-over-year revenue change (65.5% vs 21.6%). Over the past eight quarters, Lumentum Holdings Inc.'s revenue compounded faster (34.8% CAGR vs 12.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

JDS Uniphase Corporation (JDSU) was an American company that designed and manufactured products for optical communications networks, communications test and measurement equipment, lasers, optical solutions for authentication and decorative applications, and other custom optics. It was headquartered in Milpitas, California. In August 2015, JDSU split into two different companies – Viavi Solutions and Lumentum Holdings.

DXCM vs LITE — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.9× larger
DXCM
$1.3B
$665.5M
LITE
Growing faster (revenue YoY)
LITE
LITE
+43.9% gap
LITE
65.5%
21.6%
DXCM
Higher net margin
DXCM
DXCM
9.5% more per $
DXCM
21.2%
11.8%
LITE
Faster 2-yr revenue CAGR
LITE
LITE
Annualised
LITE
34.8%
12.0%
DXCM

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
DXCM
DXCM
LITE
LITE
Revenue
$1.3B
$665.5M
Net Profit
$267.3M
$78.2M
Gross Margin
62.9%
36.1%
Operating Margin
25.6%
9.7%
Net Margin
21.2%
11.8%
Revenue YoY
21.6%
65.5%
Net Profit YoY
153.6%
228.4%
EPS (diluted)
$0.67
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
LITE
LITE
Q1 26
$1.3B
Q4 25
$1.3B
$665.5M
Q3 25
$1.2B
$533.8M
Q2 25
$1.2B
$480.7M
Q1 25
$1.0B
$425.2M
Q4 24
$1.1B
$402.2M
Q3 24
$994.2M
$336.9M
Q2 24
$1.0B
$308.3M
Net Profit
DXCM
DXCM
LITE
LITE
Q1 26
$267.3M
Q4 25
$267.3M
$78.2M
Q3 25
$283.8M
$4.2M
Q2 25
$179.8M
$213.3M
Q1 25
$105.4M
$-44.1M
Q4 24
$151.7M
$-60.9M
Q3 24
$134.6M
$-82.4M
Q2 24
$143.5M
$-252.5M
Gross Margin
DXCM
DXCM
LITE
LITE
Q1 26
62.9%
Q4 25
62.9%
36.1%
Q3 25
60.5%
34.0%
Q2 25
59.5%
33.3%
Q1 25
56.9%
28.8%
Q4 24
58.9%
24.8%
Q3 24
59.7%
23.1%
Q2 24
62.4%
16.6%
Operating Margin
DXCM
DXCM
LITE
LITE
Q1 26
25.6%
Q4 25
25.6%
9.7%
Q3 25
20.1%
1.3%
Q2 25
18.4%
-1.7%
Q1 25
12.9%
-8.9%
Q4 24
17.0%
-12.8%
Q3 24
15.3%
-24.5%
Q2 24
15.7%
-43.3%
Net Margin
DXCM
DXCM
LITE
LITE
Q1 26
21.2%
Q4 25
21.2%
11.8%
Q3 25
23.5%
0.8%
Q2 25
15.5%
44.4%
Q1 25
10.2%
-10.4%
Q4 24
13.6%
-15.1%
Q3 24
13.5%
-24.5%
Q2 24
14.3%
-81.9%
EPS (diluted)
DXCM
DXCM
LITE
LITE
Q1 26
$0.67
Q4 25
$0.67
$0.89
Q3 25
$0.70
$0.05
Q2 25
$0.45
$3.10
Q1 25
$0.27
$-0.64
Q4 24
$0.37
$-0.88
Q3 24
$0.34
$-1.21
Q2 24
$0.35
$-3.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
LITE
LITE
Cash + ST InvestmentsLiquidity on hand
$917.7M
$1.2B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$846.6M
Total Assets
$6.3B
$4.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
LITE
LITE
Q1 26
$917.7M
Q4 25
$917.7M
$1.2B
Q3 25
$1.8B
$1.1B
Q2 25
$1.2B
$877.1M
Q1 25
$904.9M
$866.7M
Q4 24
$606.1M
$896.7M
Q3 24
$621.2M
$916.1M
Q2 24
$939.2M
$887.0M
Stockholders' Equity
DXCM
DXCM
LITE
LITE
Q1 26
$2.7B
Q4 25
$2.7B
$846.6M
Q3 25
$2.7B
$780.8M
Q2 25
$2.6B
$1.1B
Q1 25
$2.3B
$879.5M
Q4 24
$2.1B
$872.3M
Q3 24
$2.0B
$895.9M
Q2 24
$2.4B
$957.3M
Total Assets
DXCM
DXCM
LITE
LITE
Q1 26
$6.3B
Q4 25
$6.3B
$4.8B
Q3 25
$7.5B
$4.6B
Q2 25
$7.3B
$4.2B
Q1 25
$6.8B
$4.0B
Q4 24
$6.5B
$4.0B
Q3 24
$6.4B
$4.0B
Q2 24
$6.8B
$3.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
LITE
LITE
Operating Cash FlowLast quarter
$126.7M
Free Cash FlowOCF − Capex
$43.1M
FCF MarginFCF / Revenue
6.5%
Capex IntensityCapex / Revenue
12.6%
Cash ConversionOCF / Net Profit
1.62×
TTM Free Cash FlowTrailing 4 quarters
$-29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
LITE
LITE
Q1 26
Q4 25
$294.0M
$126.7M
Q3 25
$659.9M
$57.9M
Q2 25
$303.0M
$64.0M
Q1 25
$183.8M
$-1.6M
Q4 24
$301.4M
$24.3M
Q3 24
$199.5M
$39.6M
Q2 24
$279.4M
$35.5M
Free Cash Flow
DXCM
DXCM
LITE
LITE
Q1 26
Q4 25
$192.1M
$43.1M
Q3 25
$579.4M
$-18.3M
Q2 25
$208.9M
$10.1M
Q1 25
$96.8M
$-64.4M
Q4 24
$176.8M
$-15.9M
Q3 24
$88.3M
$-34.5M
Q2 24
$213.3M
$10.9M
FCF Margin
DXCM
DXCM
LITE
LITE
Q1 26
Q4 25
15.3%
6.5%
Q3 25
47.9%
-3.4%
Q2 25
18.1%
2.1%
Q1 25
9.3%
-15.1%
Q4 24
15.9%
-4.0%
Q3 24
8.9%
-10.2%
Q2 24
21.2%
3.5%
Capex Intensity
DXCM
DXCM
LITE
LITE
Q1 26
Q4 25
8.1%
12.6%
Q3 25
6.7%
14.3%
Q2 25
8.1%
11.2%
Q1 25
8.4%
14.8%
Q4 24
11.2%
10.0%
Q3 24
11.2%
22.0%
Q2 24
6.6%
8.0%
Cash Conversion
DXCM
DXCM
LITE
LITE
Q1 26
Q4 25
1.10×
1.62×
Q3 25
2.33×
13.79×
Q2 25
1.69×
0.30×
Q1 25
1.74×
Q4 24
1.99×
Q3 24
1.48×
Q2 24
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

LITE
LITE

Components$443.7M67%
Systems$221.8M33%

Related Comparisons